NCT04201054View on ClinicalTrials.gov

Generation of Biological Samples Positive to Fluconazole for Anti-Doping Control

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

April 5, 2019

Study Completion Date

April 5, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Fluconazole

50 mg of fluconazole administered orally in a single dose.

Trial Locations (1)

08003

IMIM (Hospital del Mar Medical Research Institute), Barcelona

All Listed Sponsors
lead

Parc de Salut Mar

OTHER

NCT04201054 - Generation of Biological Samples Positive to Fluconazole for Anti-Doping Control | Biotech Hunter | Biotech Hunter